title: Nocturnal enuresis and the use of desmopressin: is it helpful?
abstract: We assessed the outcome of the use of an enuretic alarm and desmopressin according to conventional guidelines and investigated the reasons for resistance to desmopressin. Children were given a 4 month course using an enuretic alarm if they had not previously used one; 12 out of 21 were dry (57%) after 4 months and one relapsed 1 month later. Those who had previously failed with an alarm or were considered poorly motivated to use it, were given a 4 month course of intranasal desmopressin. Of these 26 children, 10 (38%) were dry at the end of 4 months but only two (7%) remained dry after this was withdrawn. After the initial treatment with alarm or desmopressin, 27 children were still enuretic and attending the clinic. They were shown how to use the alarm and eight also used the dry bed training technique: 15 had become dry after a further 6 months. Of the 12 children who made no response to intranasal desmopressin, nine were given this medication under supervision in hospital; seven of these children still wet the bed despite producing small amounts of concentrated urine overnight. They also had small measured diurnal bladder capacities. We conclude that if a 4 month course with an enuretic alarm is unsuccessful, rather than using desmopressin, the alarm should be continued with relearning and consideration given to additional use of the dry bed training technique. The major factor causing nocturnal enuresis in children is likely to be a small nocturnal bladder capacity.
authors.affiliation: Southern Derbyshire Community Trust and Derbyshire Children's Hospital, Derby, UK.
authors.forename: R
authors.initials: R
authors.lastname: Bath
authors.forename: R
authors.initials: R
authors.lastname: Morton
authors.forename: A
authors.initials: A
authors.lastname: Uing
authors.forename: C
authors.initials: C
authors.lastname: Williams
mesh_terms: D000281:Administration, Intranasal; D000293:Adolescent; D001521:Behavior Therapy; D002648:Child; D003131:Combined Modality Therapy; D003894:Deamino Arginine Vasopressin / Q000008:administration & dosage / Q000627:therapeutic use*; D004775:Enuresis / Q000188:drug therapy* / Q000628:therapy*; D005260:Female; D006801:Humans; D008297:Male
chemical_list: D003894:Deamino Arginine Vasopressin